Straightforward But Technical: Transferring Existing Studies To EU Clinical Trial Portal
Executive Summary
At a webinar organized by the European Medicines Agency, EU member states discussed their experiences with reviewing the requests made by trial sponsors to switch existing studies to the Clinical Trial Regulation.
You may also be interested in...
Time Running Out To Switch Ongoing Studies To EU Clinical Trials Regulation
Industry and academic study sponsors have called for an urgent solution to address the administrative burden and the short timeframe remaining to move their ongoing trials authorized under the EU Clinical Trials Directive to the Clinical Trials Regulation.
Clinical Trial Regulation: EU Clarifies Requirements For Patient-Facing Documents
An updated Q&A on the EU Clinical Trial Regulation distinguishes between patient-facing documents and recruitment material to clarify in which sections of the trial application these should be submitted. It also underlines the main principles to consider for transitioning studies from the Clinical Trials Directive to the CTR.
Not A Smooth Ride: How One Of The First Studies Navigated The EU Clinical Trial Portal
From grappling with a never-ending list of conflicting national requirements to dealing with numerous technical issues, a research project manager at Norway’s Oslo University Hospital talks about the hiccups faced by their multinational COVID-19 platform trial that was among the first studies submitted for approval under the EU Clinical Trial Regulation.